Global Digital Maternal & Fetal Health Market Size (2024 – 2030)

As of 2022, the Global Digital Maternal & Fetal Health Market recorded a valuation of USD 2.94 billion, with a projected expansion to USD 4.14 billion by 2030. The anticipated growth trajectory for the market between 2024 and 2030 indicates a Compound Annual Growth Rate (CAGR) of 5%.

Industry Overview

The digital maternal and fetal health market encompasses fetal monitoring systems, diagnostic tools designed to track fetal movement, heart rate, and maternal contractions during childbirth. It serves as a fundamental instrument for monitoring uterine contractions during labor, primarily focusing on assessing the health of the fetus and the progression of labor. This medical procedure ensures a safe delivery by evaluating the unborn baby's well-being. Additionally, it aids in monitoring various conditions such as chronic lung diseases, mental disabilities, newborn disorders, hypothermia, vision and hearing impairments, and jaundice.

Market growth in the global fetal monitoring sector is propelled by several factors, including the rising prevalence of cardiopulmonary diseases, advancements in non-invasive surgical technologies, increased initiatives from government and non-governmental organizations worldwide to improve maternal and fetal health, growing awareness, and a willingness to invest in fetal monitoring advancements. The market comprises devices for measuring fetal heart rate, movement, and uterine contractions. However, challenges such as high equipment costs, a lack of standardized regulations, technical limitations, and subjective interpretations hinder the global fetal monitoring market's growth.

The market is poised for development due to the escalating demand for fetal monitoring throughout pregnancies. Technological advancements, coupled with increasing rates of preterm births and overall birth rates, are expected to drive global market growth. Additionally, factors such as the rising prevalence of conditions like preterm birth and hemorrhage, along with the demand for fetal monitoring supplements, contribute to market expansion. The emergence of portable, wireless technologies, and unexplored markets further present significant growth opportunities globally. Nevertheless, stringent regulatory processes, declining birth rates, and the high costs of equipment pose challenges to the fetal monitoring industry's worldwide growth.

Impact of COVID-19 on the Industry

The COVID-19 pandemic significantly impacted fetal monitoring operations primarily due to reduced hospital capacities and the rescheduling of procedures for safety measures. Healthcare facilities postponed fetal monitoring procedures after thorough assessments of patients' medical histories, aiming to minimize COVID-19 exposure risks during hospital visits. Moreover, areas heavily affected by COVID-19 witnessed decreased fetal surveillance due to new government directives or hospital protocols. Consequently, the pandemic has had an adverse effect on the fetal monitoring business.

Market Drivers

Advancements in cutting-edge and innovative fetal monitoring systems will propel market growth.

The fetal monitoring industry is witnessing growth with the introduction of innovative technologies and increased research leading to product advancements. Simplification of fetal monitoring technologies aims to enhance assistance in intrauterine fetal procedures, addressing challenges such as difficult fetal access and technological complexities. Noteworthy progress has been made in fetal cardiac evaluations, enabling high-fidelity hemodynamic and continuous physiological monitoring for early diagnosis and treatment.

Research and technological advancements in fetal monitoring devices have popularized non-invasive monitoring approaches. Obstetrics now includes non-invasive diagnostic tools such as Doppler tests, cell-free fetal DNA evaluations, electronic fetal monitoring (EFM), and assessments of fetal acid-base status. Procedures such as percutaneous umbilical cord blood collection during pregnancy and fetal scalp blood sampling immediately after birth are becoming commonplace. Advanced data collection methods, merged with fetal phonocardiography, aim to enhance the efficiency of fetal monitoring data processing. Researchers are focusing on sophisticated data analytics, synthetic data generation using complex mathematical models, and classification and processing algorithms to improve fetal monitoring efficacy.

Development of Non-Invasive, Portable, and Advanced Fetal Monitors

Leading market manufacturers are expanding their product portfolios to offer accurate, safe, and affordable portable and wireless monitoring systems. Telecommunications integration into these devices is also a notable trend among major companies. In 2020, Philips introduced Lumify, a portable tele-ultrasound system in Japan, alongside Avalon CL in the United States. Additionally, a strategic partnership between MindChild Medical and Henry Schein Medical in 2019 boosted the sales and distribution of the MERIDIAN M110 Fetal Monitoring System, a non-invasive intrapartum monitor, in the United States.

Market Restraints

High Costs of Fetal Monitoring Equipment

The adoption of superior fetal monitoring technologies comes with significant expenses. Advanced monitoring techniques, such as Doppler ultrasound devices, are notably costly. For instance, Doppler technology probes, like the Philips Doppler transducer, range from $4,500 to $17,000, while the GE Healthcare SonoScape system costs approximately USD 9,000. Maintenance costs, accounting for 15% of the equipment's purchase price, further add to the financial burden. Such high costs may limit market growth, particularly in low-income countries and institutions with limited financial resources.

The global maternal and fetal health market, categorized by product type, encompasses a range of essential medical devices:

• Ultrasound Devices
  • 2D Ultrasound
  • 3D & 4D Ultrasound
  • Doppler Imaging
• Electronic Maternal/Fetal Monitors
  • Uterine Contraction Monitors
    • Internal Uterine Contraction Monitors
    • External Uterine Contraction Monitors
  • Fetal Electrodes
  • Fetal Doppler Devices
  • Telemetry Devices

Comprising ultrasound equipment, electronic maternal/fetal monitors, fetal electrodes, fetal doppler devices, uterine contraction monitors, telemetry devices, as well as accessories & consumables, this market is predominantly led by ultrasound devices. Factors such as technological advancements, increased incidences of congenital malformations, maternal mortality rates, and growing regulatory approvals are propelling the growth of this segment.

The global maternal and fetal health market is further segmented based on methodology into:

• Invasive
• Non-invasive

In 2020, the non-invasive segment held the largest market share. Non-invasive methods for fetal diagnosis and monitoring, particularly in high-risk pregnancies, are widely recognized. This segment's growth is fueled by the increasing approval of various non-invasive monitoring devices and the introduction of advanced technologies.

Segmented by application, the market is categorized into:

• Antepartum
• Intrapartum

Antepartum fetal monitoring, conducted throughout pregnancies to detect congenital fetal anomalies, commands the largest market share in fetal monitoring. The growth of the antepartum segment is driven by comprehensive monitoring protocols, recent product launches, the rising incidence of fetal abnormalities, and maternal mortality rates.

Geographically, the global maternal and fetal health market spans regions including:

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa

The Asia-Pacific region presents lucrative opportunities for key players in the fetal monitoring market due to increasing awareness of fetal monitoring and rising disposable incomes. The demand for advanced fetal monitoring equipment is also a significant driver of market growth in this region. Additionally, the Asia-Pacific region, notably populated by countries such as India and China, stands to benefit from a rise in pregnancy cases, further boosting the fetal monitoring market.

Notable occurrences in the global digital maternal and fetal health market include:

• Product Launch (2020):Koninklijke Philips N.V. introduced the Avalon CL Fetal and Maternal Pod and Patch in the United States.
• Product Launch (2020):SonoSite unveiled the SonoSite PX Ultrasound System in the United States under FUJIFILM UroLift.